For 90 years, McGinnis Lochridge has served to protect the interests of our clients in continuously changing landscapes including cutting-edge technology, oil and gas litigation, regulatory matters and more. The quality of our work is reflected in our clients’ long-lasting loyalty and in our top-tier external rankings.
Ali focuses her corporate practice on the commercialization of new companies’ products and services, and emerging technologies. Ali has decades of experience working with a wide variety of corporations, especially in the medical device field as key management, Chief Privacy Officer and in-house legal counsel. She has an extensive background in manufacturing, product labeling, FDA regulatory oversight and post-market compliance for both consumer goods and FDA medical devices. Ali has also managed angel/venture capital financing including preparing for an initial public offering, drafting convertible notes, simple agreements for equity and/or other seed-stage investments.
Ali and her team will focus on early stage growth companies working with them to incorporate, establish equity incentive plans, negotiate licensing agreements for the company’s technology and manage the day to day matters all start-up companies face.
Prior to joining McGinnis Lochridge, Ali held senior executive positions in several start-up businesses, including both private and publicly traded medical device corporations. She was appointed to and served a term of four years as industry representative to the FDA’s orthopedic medical device panel. Most recently, she sold another start-up company in the health and beauty area to a foreign global corporation and now remains a consultant to their business. Before graduating from law school, Ali was a nurse practitioner in emergency medicine.